使用蒽环类药物阿霉素是限制其心脏毒性。
The use of the anthracycline doxorubicin is restricted by its cardiac toxicity.
目的：观察参芪扶正液抗蒽环类药物化疗所致心脏毒性的作用。
Objective To observe the heart protection effect of parenteral solution Shenqifuzheng in the chemotherapy with marcellomycin.
本研究旨在观察右丙亚胺治疗蒽环类药物外渗的有效性和安全性。
The purpose of this study was to assess the efficacy and safety of the treatment of anthracycline extravasation with dexrazoxane.
目的：探讨参麦注射液治疗蒽环类药物所致心脏毒性的疗效与不良反应。
Objective: to investigate the therapeutic effect and toxicity of Shenmai injection treatment for patients with cardiotoxicity of anthracycline.
方法对近年来10例乳腺癌术后蒽环类药物化疗渗漏损伤的病例进行回顾性总结。
Method Retrospective analysis of 10 cases of breast cancer patients with drug-effusion induced by postoperative anthracene-based chemotherapy.
入组的所有305名女性(中位年龄55岁)当中要么已是乳癌晚期患者，要么是乳癌转移患者，而且都接受了蒽环类药物的治疗。
All 305 women in the study (median age 55 years) had locally advanced or metastatic breast cancer, and all had been treated with an anthracycline.
对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P<0。01）。
Results In primary breast cancer, the antitumor effect of taxane is better than anthracycline and gemcitabine(P <0.01).
目前乳腺癌辅助化疗应用最多的仍是蒽环类及紫杉类药物。
Nowaday, the chemotherapeutic drugs of anthracycline and taxane are used widely in breast cancer.
目前乳腺癌辅助化疗应用最多的仍是蒽环类及紫杉类药物。
Nowaday, the chemotherapeutic drugs of anthracycline and taxane are used widely in breast cancer.
应用推荐